LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 61.56 | 27.76 | 4603 | 6217 | 0.7404 | 0.9245 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 63.26 | 27.76 | 162 | 6465 | 0.0251 | 0.2515 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 63.26 | 27.76 | 5124 | 6465 | 0.7925 | 0.9417 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 63.26 | 27.76 | 1669 | 6465 | 0.2581 | 0.6836 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 63.26 | 27.76 | 4894 | 6465 | 0.7569 | 0.9304 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 64.97 | 27.76 | 164 | 6656 | 0.0246 | 0.2519 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 64.97 | 27.76 | 5361 | 6656 | 0.8053 | 0.9460 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 64.97 | 27.76 | 1809 | 6656 | 0.2718 | 0.6961 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 64.97 | 27.76 | 5153 | 6656 | 0.7741 | 0.9363 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 66.67 | 27.76 | 202 | 6695 | 0.0302 | 0.2850 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 66.67 | 27.76 | 5579 | 6695 | 0.8332 | 0.9544 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 66.67 | 27.76 | 1887 | 6695 | 0.2818 | 0.7042 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 66.67 | 27.76 | 5371 | 6695 | 0.8022 | 0.9451 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 68.37 | 27.76 | 234 | 6879 | 0.0340 | 0.3074 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 68.37 | 27.76 | 5860 | 6879 | 0.8518 | 0.9601 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 68.37 | 27.76 | 2045 | 6879 | 0.2973 | 0.7171 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 68.37 | 27.76 | 5671 | 6879 | 0.8244 | 0.9520 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 70.08 | 27.76 | 243 | 6849 | 0.0355 | 0.3139 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 70.08 | 27.76 | 6019 | 6849 | 0.8787 | 0.9677 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 70.08 | 27.76 | 2236 | 6849 | 0.3264 | 0.7372 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 70.08 | 27.76 | 5768 | 6849 | 0.8421 | 0.9572 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 71.78 | 27.76 | 194 | 6893 | 0.0281 | 0.2768 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 71.78 | 27.76 | 6233 | 6893 | 0.9042 | 0.9749 | MN20160318_Q01 | I13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 71.78 | 27.76 | 2349 | 6893 | 0.3408 | 0.7469 | MN20160318_Q01 | K13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 71.78 | 27.76 | 6047 | 6893 | 0.8773 | 0.9674 | MN20160318_Q01 | K13 |